Literature DB >> 6611455

Modulation of glucocorticoid receptors by mitogenic stimuli, glucocorticoids and retinoids in normal human cultured T cells.

A Lacroix, G D Bonnard, M E Lippman.   

Abstract

Human T lymphocytes can be maintained in cell culture by the addition of conditioned medium (CM) containing a T cell growth factor (TCGF). This system provides an opportunity to study the presence and modulation of glucocorticoid receptors (GR) by various factors in these cells. GR were present in T cells grown from each of 22 normal individuals; the binding capacity (mean = 3851 +/- 2880 sites/cell) and affinity (Kd = 7.4 X 10(-9)) were similar in rested cultured T cells (CTC) to those reported in peripheral blood T lymphocytes. Treatment of rested CTC with stimuli such as phytohemagglutinin (PHA), CM, or 12-O-tetradecanoylphorbol-13-acetate (TPA) results in a mean increase in GR binding capacity of 3.1-, 3.2- or 2.4-fold respectively without modification of binding affinity. Using an exchange assay to measure occupied and unoccupied GR, we examined the effects of cortisol on its own receptor. Treatment of rested CTC with 10(-7) M cortisol for 24 h decreased GR by more than 50%. Cortisol treatment also blocked the induction of GR by PHA and CM. Since retinoids have been shown to modulate the immune response and to alter the effects of PHA and phorbol esters on lymphocytes, we examined their effects on GR. Retinol decreased GR activity in CTC but only at concentrations which inhibit cell growth. It is concluded that GR activity in human T cells can be modulated by several important factors involved in lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611455     DOI: 10.1016/0022-4731(84)90062-1

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  9 in total

1.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

2.  New insight into dexamethasone activity in lymphoblast transformation of mouse thymocytes.

Authors:  B Bertin; J Buré; J L Junien; V Levièvre
Journal:  Agents Actions       Date:  1986-12

3.  The promoter and first, untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites.

Authors:  J Zong; J Ashraf; E B Thompson
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  Gamma interferon down-regulates glucocorticoid receptor expression and attenuates hormone action in a human osteosarcoma cell line.

Authors:  L N Song
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

5.  Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

6.  Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.

Authors:  Juan Du; Min Li; Denghai Zhang; Xiaoyan Zhu; Weiwei Zhang; Wei Gu; Yinglu Feng; Xiaofeng Zhai; Changquan Ling
Journal:  Arthritis Res Ther       Date:  2009-07-14       Impact factor: 5.156

7.  Glucocorticoid receptors in mononuclear blood cells and their correlation to endogenous and exogenous corticoids in healthy and asthmatic children.

Authors:  M Griese; G Kusenbach; K Lüsebring; W Köster; B Roth; D Reinhardt
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

Review 8.  Molecular mechanisms regulating glucocorticoid sensitivity and resistance.

Authors:  Katherine L Gross; Nick Z Lu; John A Cidlowski
Journal:  Mol Cell Endocrinol       Date:  2008-10-19       Impact factor: 4.102

9.  An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease.

Authors:  D Rutkowski; F Syed; L C Matthews; D W Ray; D A McGrouther; R E B Watson; A Bayat
Journal:  Br J Dermatol       Date:  2015-07-28       Impact factor: 9.302

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.